XBiotech Inc.
XBIT
$8.61
-$0.72-7.72%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.64M | -7.36M | -8.74M | -3.82M | -3.20M |
| Total Depreciation and Amortization | 434.00K | 432.00K | 435.00K | 443.00K | 443.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -559.00K | 2.02M | -414.00K | 322.00K | -2.03M |
| Change in Net Operating Assets | 1.33M | 3.43M | -276.00K | -1.76M | 1.63M |
| Cash from Operations | -3.43M | -1.49M | -9.00M | -4.81M | -3.16M |
| Capital Expenditure | -115.00K | -33.00K | -208.00K | -6.00K | -132.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 61.86M | -- | -- | -3.78M |
| Cash from Investing | -115.00K | 61.83M | -208.00K | -6.00K | -3.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 5.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -14.00K | -- | -- |
| Cash from Financing | 0.00 | 5.00K | -14.00K | -- | -- |
| Foreign Exchange rate Adjustments | 1.38M | -1.54M | 126.00K | -8.00K | 3.81M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.17M | 58.80M | -9.09M | -4.82M | -3.26M |
